Literature DB >> 26581909

MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF.

Jianting Long1, Chunlin Jiang2, Baoxian Liu3, Shi Fang4,5, Ming Kuang6.   

Abstract

We examined the expression pattern and functional roles of microRNA 15a-5p (miR-15a-5p) in human hepatocellular carcinoma (HCC). Possible miR-15a-5p aberrant expression in HCC cell lines or clinical HCC specimens was examined by quantitative real-time PCR (qRT-PCR). In HCC HepG2 and SNU-182 cells, miR-15a-5p was ectopically overexpressed by lentiviral transduction. Its effect on HCC proliferation, cancer division, and in vivo tumor growth were examined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, cell cycle assay, and tumorigenicity assay, respectively. The targeting of miR-15a-5p on its downstream gene, brain-derived neurotrophic factor (BDNF), was examined by dual-luciferase assay, qRT-PCR, and Western blot, respectively. BDNF was then overexpressed in HepG2 and SNU-182 cells to evaluate its selective effect on miR-15a-5p in HCC modulation. MiR-15a-5p is aberrantly downregulated in in vitro HCC cell lines and in vivo HCC clinical specimens. Ectopic overexpression of miR-15a-5p suppressed cancer proliferation, induced cell cycle arrest in HepG2 or SNU-182 cells in vitro, and inhibited HCC tumor growth in vivo. MiR-15a-5p selectively and negatively regulated BDNF at both gene and protein levels in HCC cells. Forced overexpression of BDNF effectively reversed the tumor suppressive functions of miR-15a-5p on HCC proliferation and cell division in vitro. Our study demonstrated that miR-15a-5p is a tumor suppressor in HCC and its regulation is through BDNF in HCC.

Entities:  

Keywords:  BDNF; Cancer proliferation; Cell cycle; Hepatocellular carcinoma; miR-15a-5p

Mesh:

Substances:

Year:  2015        PMID: 26581909     DOI: 10.1007/s13277-015-4427-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  21 in total

Review 1.  Neurotrophins and neuronal differentiation in the central nervous system.

Authors:  A K McAllister
Journal:  Cell Mol Life Sci       Date:  2001-07       Impact factor: 9.261

Review 2.  Targeted therapies in hepatocellular carcinoma.

Authors:  F Bronte; G Bronte; S Cusenza; E Fiorentino; C Rolfo; G Cicero; E Bronte; V Di Marco; A Firenze; G Angarano; T Fontana; A Russo
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

3.  The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.

Authors:  Fang Zheng; Yi-Ji Liao; Mu-Yan Cai; Yan-Hui Liu; Tian-Hao Liu; Shu-Peng Chen; Xiu-Wu Bian; Xin-Yuan Guan; Marie C Lin; Yi-Xin Zeng; Hsiang-Fu Kung; Dan Xie
Journal:  Gut       Date:  2011-06-14       Impact factor: 23.059

4.  Hypothalamic gene transfer of BDNF inhibits breast cancer progression and metastasis in middle age obese mice.

Authors:  Xianglan Liu; Travis McMurphy; Run Xiao; Andrew Slater; Wei Huang; Lei Cao
Journal:  Mol Ther       Date:  2014-03-18       Impact factor: 11.454

5.  Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition.

Authors:  Lei Cao; Xianglan Liu; En-Ju D Lin; Chuansong Wang; Eugene Y Choi; Veronique Riban; Benjamin Lin; Matthew J During
Journal:  Cell       Date:  2010-07-09       Impact factor: 41.582

6.  Large-scale screening identifies a novel microRNA, miR-15a-3p, which induces apoptosis in human cancer cell lines.

Authors:  Aliaksandr Druz; Yu-Chi Chen; Rajarshi Guha; Michael Betenbaugh; Scott E Martin; Joseph Shiloach
Journal:  RNA Biol       Date:  2013-01-25       Impact factor: 4.652

7.  Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma.

Authors:  Yang Li; Weiqi Tan; Thomas W L Neo; Myat O Aung; Shanthi Wasser; Seng G Lim; Theresa M C Tan
Journal:  Cancer Sci       Date:  2009-04-15       Impact factor: 6.716

8.  miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.

Authors:  Nora Bandi; Samuel Zbinden; Mathias Gugger; Marlene Arnold; Verena Kocher; Lara Hasan; Andreas Kappeler; Thomas Brunner; Erik Vassella
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

Review 9.  Systemic therapy of hepatocellular carcinoma: current status and future perspectives.

Authors:  Domenico Germano; Bruno Daniele
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

10.  More expressions of BDNF and TrkB in multiple hepatocellular carcinoma and anti-BDNF or K252a induced apoptosis, supressed invasion of HepG2 and HCCLM3 cells.

Authors:  Dawei Guo; Xuezhong Hou; Hongbin Zhang; Wenyu Sun; Lei Zhu; Jian Liang; Xiaofeng Jiang
Journal:  J Exp Clin Cancer Res       Date:  2011-10-14
View more
  17 in total

Review 1.  BDNF and its signaling in cancer.

Authors:  Mohammad Malekan; Sasan Salehi Nezamabadi; Elham Samami; Mehdi Mohebalizadeh; Amene Saghazadeh; Nima Rezaei
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-29       Impact factor: 4.322

2.  MiR-15a-5p negatively regulates cell survival and metastasis by targeting CXCL10 in chronic myeloid leukemia.

Authors:  Dan Chen; Dijiong Wu; Keding Shao; Baodong Ye; Jian Huang; Yanting Gao
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

3.  Therapeutic effects of oligo-single-stranded DNA mimicking of hsa-miR-15a-5p on multiple myeloma.

Authors:  Zhongqing Li; Lanting Liu; Chenxing Du; Zhen Yu; Yuanyuan Yang; Jie Xu; Xiaojing Wei; Fenghuang Zhan; Yongrong Lai; Lugui Qiu; Mu Hao
Journal:  Cancer Gene Ther       Date:  2020-01-28       Impact factor: 5.987

4.  Alterations in Plasma microRNA and Protein Levels in War Veterans with Chronic Mild Traumatic Brain Injury.

Authors:  Vikas Ghai; Shannon Fallen; David Baxter; Kelsey Scherler; Taek-Kyun Kim; Yong Zhou; James S Meabon; Aric F Logsdon; William A Banks; Abigail G Schindler; David G Cook; Elaine R Peskind; Inyoul Lee; Kai Wang
Journal:  J Neurotrauma       Date:  2020-03-11       Impact factor: 5.269

5.  Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis.

Authors:  Lin-Pei Wang; Jing Lin; Xiao-Qiu Ma; Dong-Yao Xu; Chun-Feng Shi; Wei Wang; Xiao-Jie Jiang
Journal:  J Exp Clin Cancer Res       Date:  2021-05-26

6.  MicroRNA-497 inhibits thyroid cancer tumor growth and invasion by suppressing BDNF.

Authors:  Peisong Wang; Xianying Meng; Yan Huang; Zhi Lv; Jia Liu; Guimin Wang; Wei Meng; Shuai Xue; Qiang Zhang; Pengju Zhang; Guang Chen
Journal:  Oncotarget       Date:  2017-01-10

7.  MicroRNA-147 targets BDNF to inhibit cell proliferation, migration and invasion in non-small cell lung cancer.

Authors:  Fang Li; Xianfang Wang; Lingling Yang
Journal:  Oncol Lett       Date:  2020-06-09       Impact factor: 2.967

8.  Knockdown of lncRNA PVT1 inhibits prostate cancer progression in vitro and in vivo by the suppression of KIF23 through stimulating miR-15a-5p.

Authors:  Huijuan Wu; Xin Tian; Chaoyang Zhu
Journal:  Cancer Cell Int       Date:  2020-07-02       Impact factor: 5.722

9.  MicroRNA-15a-5p serves as a potential biomarker and regulates the viability and apoptosis of hippocampus neuron in children with temporal lobe epilepsy.

Authors:  Na Li; Jingmei Pan; Wei Liu; Yuanyuan Li; Feng Li; Min Liu
Journal:  Diagn Pathol       Date:  2020-05-08       Impact factor: 2.644

10.  Effect of valproic acid on miRNAs affecting histone deacetylase in a model of anaplastic thyroid cancer.

Authors:  Nur Selvi Gunel; Nihal Birden; Cansu Caliskan Kurt; Bakiye Goker Bagca; Behrouz Shademan; Fatma Sogutlu; Neslihan Pinar Ozates; Cigir Biray Avci
Journal:  Mol Biol Rep       Date:  2021-08-10       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.